0000950170-24-100209.txt : 20240823 0000950170-24-100209.hdr.sgml : 20240823 20240823163004 ACCESSION NUMBER: 0000950170-24-100209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240821 FILED AS OF DATE: 20240823 DATE AS OF CHANGE: 20240823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shook David CENTRAL INDEX KEY: 0001959742 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 241236684 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0508 4 2024-08-21 0001787400 Nkarta, Inc. NKTX 0001959742 Shook David C/O NKARTA, INC. 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 false true false false See Remarks false Common Stock 2024-08-21 4 A false 1352 5.11 D 138593 D Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person. Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2024. Chief Medical Officer, Head of Research & Development /s/ Alicia Hager, as Attorney-in-Fact 2024-08-23